Boris Predovich, serving in the capacity of President and Chief Executive Officer, co-founded PreLabs in collaboration with the existing Biologic Safety Research (BSR) management team. He leads an organization responsible for supporting a sustainable growth strategy focused on understanding the client's outsourcing requirements while expanding on BSR's 20 years of existing scientific and operational services.

Over the last 25 years, Boris gained extensive international business experience in the biomedical research and real estate sectors. Boris' training and corporate experience was developed by working in various roles of increasing responsibility including sales, marketing, business development, and acquisitions and divestitures. He founded two start-up organizations and utilized his business rigor and discipline to manage the financial responsibilities of various business entities.

In his most recent role, he served as Vice President for Covance Inc. This provided him the opportunity to build a team that was instrumental in creating and expanding the newly formed ImmunoTechnologies division. The group focused on creating a globally competitive outsourcing capability in immunology and preclinical vaccine/biologics services. Over a three year period, the business unit increased operating revenues three fold and doubled the staff by defining core capabilities, acquiring a new business to expand the immunology footprint, and building a state-of-the-art vaccine and biologics biocontainment vivarium to meet increased client demand.

Mr. Predovich received his B.S. degree in Business Management from Northern Illinois University in De Kalb, Illinois. He is currently serving on the Board of Director's of the California Society for Biomedical Research and is the Chair of the California Biomedical Research Association.

Boris Predovich, serving in the capacity of President and Chief Executive Officer, co-founded PreLabs in collaboration with the existing Biologic Safety Research (BSR) management team. He leads an organization responsible for supporting a sustainable growth strategy focused on understanding the client's outsourcing requirements while expanding on BSR's 20 years of existing scientific and operational services.

Over the last 25 years, Boris gained extensive international business experience in the biomedical research and real estate sectors. Boris' training and corporate experience was developed by working in various roles of increasing responsibility including sales, marketing, business development, and acquisitions and divestitures. He founded two start-up organizations and utilized his business rigor and discipline to manage the financial responsibilities of various business entities.

In his most recent role, he served as Vice President for Covance Inc. This provided him the opportunity to build a team that was instrumental in creating and expanding the newly formed ImmunoTechnologies division. The group focused on creating a globally competitive outsourcing capability in immunology and preclinical vaccine/biologics services. Over a three year period, the business unit increased operating revenues three fold and doubled the staff by defining core capabilities, acquiring a new business to expand the immunology footprint, and building a state-of-the-art vaccine and biologics biocontainment vivarium to meet increased client demand.

Mr. Predovich received his B.S. degree in Business Management from Northern Illinois University in De Kalb, Illinois. He is currently serving on the Board of Director's of the California Society for Biomedical Research and is the Chair of the California Biomedical Research Association.

Philippe Baneux, DVM, Dipl. ECLAM, joined PreLabs in 2008 as Chief Scientific Officer. In this capacity, he oversees the scientific direction of the company and seeks to identify and integrate new technologies along with expanding the strategic partnerships to support industry outsourcing requirements.

He has over 30 years of international experience in leading scientific teams through successful outcomes in different fields including preclinical toxicology and pharmacology research conducting safety evaluation studies in the early and full development of drug candidates.

Dr. Baneux brings a unique appreciation to preclinical outsourcing complexities as a result of his broad range of industry and academic appointments. During his twelve years at Pfizer he held various positions of increasing responsibility, including Deputy Director of the Department of Toxicology, Comparative Medicine & Safety Pharmacology. He was an active member of the Global Outsourcing Team, reviewing the various international animal welfare aspects at sites where optimal outcomes would be achieved. Additionally, he participated in the Strategic Alliance Project where joint Pfizer-University-Governmental Research Units worked together to deliver a bio-imaging project. Other responsibilities included oversight, appropriateness, and application of all animal care and use SOP's assuring full compliance with applicable regulatory requirements, including FDA (GLP) and OECD regulations, and USDA, European and French laws.

Furthermore, Dr. Baneux has extensive academic experience serving in various positions including Executive Director of the Center for Comparative Medicine at Northwestern University as well as within the University of California and University of Southern California programs as a Director and Campus Veterinarian. He is a founding board member of the International Association of Colleges of Laboratory Animal Medicine (IACLAM), representing the European College of Laboratory Animal Medicine (ECLAM). Dr. Baneux is an active member in the American Association of Laboratory Animal Science (AALAS) and the American Society of Laboratory Animal Practitioners (ASLAP). Dr. Baneux has authored and co-authored several scientific articles along with lecturing and presenting at many industry functions. He is a member of the Council on Accreditation of the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International.

Dr. Baneux holds a B.S. in Veterinary Science from the State University Center, Antwerp, Belgium, a Doctorate in Veterinary Medicine from the Royal University, Gent, Belgium and a veterinary license in the State of California. Dr. Baneux is fluent in French, Dutch, and English and speaks Spanish and Portuguese.

Philippe Baneux, DVM, Dipl. ECLAM, joined PreLabs in 2008 as Chief Scientific Officer. In this capacity, he oversees the scientific direction of the company and seeks to identify and integrate new technologies along with expanding the strategic partnerships to support industry outsourcing requirements.

He has over 30 years of international experience in leading scientific teams through successful outcomes in different fields including preclinical toxicology and pharmacology research conducting safety evaluation studies in the early and full development of drug candidates.

Dr. Baneux brings a unique appreciation to preclinical outsourcing complexities as a result of his broad range of industry and academic appointments. During his twelve years at Pfizer he held various positions of increasing responsibility, including Deputy Director of the Department of Toxicology, Comparative Medicine & Safety Pharmacology. He was an active member of the Global Outsourcing Team, reviewing the various international animal welfare aspects at sites where optimal outcomes would be achieved. Additionally, he participated in the Strategic Alliance Project where joint Pfizer-University-Governmental Research Units worked together to deliver a bio-imaging project. Other responsibilities included oversight, appropriateness, and application of all animal care and use SOP's assuring full compliance with applicable regulatory requirements, including FDA (GLP) and OECD regulations, and USDA, European and French laws.

Furthermore, Dr. Baneux has extensive academic experience serving in various positions including Executive Director of the Center for Comparative Medicine at Northwestern University as well as within the University of California and University of Southern California programs as a Director and Campus Veterinarian. He is a founding board member of the International Association of Colleges of Laboratory Animal Medicine (IACLAM), representing the European College of Laboratory Animal Medicine (ECLAM). Dr. Baneux is an active member in the American Association of Laboratory Animal Science (AALAS) and the American Society of Laboratory Animal Practitioners (ASLAP). Dr. Baneux has authored and co-authored several scientific articles along with lecturing and presenting at many industry functions. He is a member of the Council on Accreditation of the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International.

Dr. Baneux holds a B.S. in Veterinary Science from the State University Center, Antwerp, Belgium, a Doctorate in Veterinary Medicine from the Royal University, Gent, Belgium and a veterinary license in the State of California. Dr. Baneux is fluent in French, Dutch, and English and speaks Spanish and Portuguese.

Thomas Welsh, DVM, PhD, DACLAM, joined PreLabs in 2008 as the Vice President for Veterinary Affairs. In this capacity, he serves as the senior corporate veterinarian responsible for managing the veterinary and regulatory compliance concerns including animal care, biosafety, security and emergency preparedness. Since 1989, he has worked for Biologic Safety Research Inc. in a similar capacity.

He has over 30 years of comprehensive toxicology experience in laboratory animal medicine, experimental design, pathology, and vivarium design and management. Tom has served on numerous Institutional Animal Care and Use Committees throughout his career and brings industry rigor to expediting the protocol review process. Furthermore, he has extensive expertise with various species including non-human primates.

Dr. Welsh's unique educational and industry background has enabled him to leverage his Veterinary and Pathology degrees in the CRO, academic, and consultancy settings. Throughout his career he has held various positions including Captain in the United States Veterinary Corps, Director at Northwestern University-Center for Comparative Medicine, Director at Rush University-Comparative Research Center, Assistant Professor of Immunology-Microbiology, Assistant Professor of Pathology as well as numerous consulting roles in industry and academia. He also served as a veterinary consultant for The World Book Medical Encyclopedia. His consulting expertise spans multiple areas of laboratory animal medicine including facility design, operations, and regulatory compliance having worked in team settings designing state-of-the-art vivariums.

Dr. Welsh holds a B.S. degree in Veterinary Science and a Doctorate in Veterinary Medicine from Oklahoma State University. Additionally, he holds a Ph.D. in Pathology from the University of Illinois and is a licensed veterinarian in the states of Illinois and California. He is a Diplomate of the American College of Laboratory Animal Medicine and has served as an Ad Hoc consultant for the Association for Assessment and Accreditation of Laboratory Animal Care International. Dr. Welsh has authored and co-authored several scientific publications along with presenting at numerous industry functions.

Thomas Welsh, DVM, PhD, DACLAM, joined PreLabs in 2008 as the Vice President for Veterinary Affairs. In this capacity, he serves as the senior corporate veterinarian responsible for managing the veterinary and regulatory compliance concerns including animal care, biosafety, security and emergency preparedness. Since 1989, he has worked for Biologic Safety Research Inc. in a similar capacity.

He has over 30 years of comprehensive toxicology experience in laboratory animal medicine, experimental design, pathology, and vivarium design and management. Tom has served on numerous Institutional Animal Care and Use Committees throughout his career and brings industry rigor to expediting the protocol review process. Furthermore, he has extensive expertise with various species including non-human primates.

Dr. Welsh's unique educational and industry background has enabled him to leverage his Veterinary and Pathology degrees in the CRO, academic, and consultancy settings. Throughout his career he has held various positions including Captain in the United States Veterinary Corps, Director at Northwestern University-Center for Comparative Medicine, Director at Rush University-Comparative Research Center, Assistant Professor of Immunology-Microbiology, Assistant Professor of Pathology as well as numerous consulting roles in industry and academia. He also served as a veterinary consultant for The World Book Medical Encyclopedia. His consulting expertise spans multiple areas of laboratory animal medicine including facility design, operations, and regulatory compliance having worked in team settings designing state-of-the-art vivariums.

Dr. Welsh holds a B.S. degree in Veterinary Science and a Doctorate in Veterinary Medicine from Oklahoma State University. Additionally, he holds a Ph.D. in Pathology from the University of Illinois and is a licensed veterinarian in the states of Illinois and California. He is a Diplomate of the American College of Laboratory Animal Medicine and has served as an Ad Hoc consultant for the Association for Assessment and Accreditation of Laboratory Animal Care International. Dr. Welsh has authored and co-authored several scientific publications along with presenting at numerous industry functions.

Donald Waller, PhD, DABT is a board certified toxicologist with extensive expertise in assisting national and international clients with their IND and IED preparations for FDA submissions. He has served as Director of Toxicology for Biologic Safety Research Inc since 1989 and has led the scientific transition into PreLabs in 2008.

Over the last 30 years Don has been an active academic research professor and CRO toxicologist managing and directing numerous studies in a variety of scientific fields. He was responsible for establishing two GLP toxicology research facilities, one in an academic setting and the other with Biologic Safety Research. His comprehensive toxicology and pharmacology research background includes experience in formulation development, efficacy screening and testing, metabolism, toxicology testing, and analytical chemistry. Dr. Waller provides a wealth of consulting expertise in study design, protocol development, report writing, regulatory/ethics compliance, and expedited IACUC approval.

Dr. Waller has served as a consultant for many biotechnology and pharmaceutical companies, governmental agencies, and private foundations including a ten-year World Health Organization sponsored project which included 11 sites around the world focused on botanicals as a source of new drug entities. As cofounder of a consortium of Universities which investigated and developed drugs to prevent sexually transmitted diseases in women, he fostered several leads to clinical trials, the establishment of drug GMP standards at international sites, the development of a preclinical testing program, and the preparation of the IND's to support the products.

Furthermore, Dr Waller has successfully leveraged his extensive academic training and university experience to provide broader based solutions to industry, academia, governmental agencies, and private foundations. He has co-patented several products, authored and co-authored numerous book chapters/reviews, peer reviewed articles and published abstracts and has been invited to speak on a wide range of scientific topics around the world.

Dr. Waller received his B.A. in Chemistry from Kalamazoo College and his PhD from Ohio State University with a focus on Pharmacology and Toxicology. He served in the United States Army as 1st Lieutenant, Staff Officer, Chemical Corps.

Donald Waller, PhD, DABT is a board certified toxicologist with extensive expertise in assisting national and international clients with their IND and IED preparations for FDA submissions. He has served as Director of Toxicology for Biologic Safety Research Inc since 1989 and has led the scientific transition into PreLabs in 2008.

Over the last 30 years Don has been an active academic research professor and CRO toxicologist managing and directing numerous studies in a variety of scientific fields. He was responsible for establishing two GLP toxicology research facilities, one in an academic setting and the other with Biologic Safety Research. His comprehensive toxicology and pharmacology research background includes experience in formulation development, efficacy screening and testing, metabolism, toxicology testing, and analytical chemistry. Dr. Waller provides a wealth of consulting expertise in study design, protocol development, report writing, regulatory/ethics compliance, and expedited IACUC approval.

Dr. Waller has served as a consultant for many biotechnology and pharmaceutical companies, governmental agencies, and private foundations including a ten-year World Health Organization sponsored project which included 11 sites around the world focused on botanicals as a source of new drug entities. As cofounder of a consortium of Universities which investigated and developed drugs to prevent sexually transmitted diseases in women, he fostered several leads to clinical trials, the establishment of drug GMP standards at international sites, the development of a preclinical testing program, and the preparation of the IND's to support the products.

Furthermore, Dr Waller has successfully leveraged his extensive academic training and university experience to provide broader based solutions to industry, academia, governmental agencies, and private foundations. He has co-patented several products, authored and co-authored numerous book chapters/reviews, peer reviewed articles and published abstracts and has been invited to speak on a wide range of scientific topics around the world.

Dr. Waller received his B.A. in Chemistry from Kalamazoo College and his PhD from Ohio State University with a focus on Pharmacology and Toxicology. He served in the United States Army as 1st Lieutenant, Staff Officer, Chemical Corps.

Michael Kukulinski B.S., L.A.T.G., transitioned into PreLabs in 2008 as Vice President of Operations. Previously, Mike co-founded and served as Vice President of Operations for Biologic Safety Research (BSR) since 1989. In this capacity, he will continue to be instrumental in strategically managing the overall business with a dedicated focus on delivering operational excellence for the newly expanded business.

He has over 30 years of experience in managing vivarium operations as well as serving as study director on thousands of studies ranging from Discovery to Safety Assessment. Mike has established and managed GLP toxicology research operations in AAALAC International-accredited vivaria over the last twenty years. His facility management expertise provides comprehensive facility oversight including regulatory compliance, animal husbandry, technician and toxicological training programs, operational integrity, client confidentiality, on site 24/7 monitored environmental and security systems, along with a focus on expediting protocols through the IACUC process.

Mike has spent most of his career in the CRO environment and has an in-depth understanding and appreciation for regulatory compliance with the Food and Drug Administration (FDA), Consumer Products Safety Commissions Regulations (CPSC), Environmental Protection Agency (EPA/FIFRA & TSCA), Department of Transportation (DOT), Organization for Economic Cooperation and Development (OECD), and other various agencies. He has consulted and conducted toxicity studies on consumer products, industrial chemicals, and components and drug evaluations.

Mr. Kukulinski holds a B.S. degree in Biology with a minor in Chemistry from Ashland University in Ashland, Ohio. He is a certified Laboratory Animal Technologist who also earned an Ophthalmic Toxicology certificate from The Institute for Applied Pharmaceutical Sciences. Michael has co-authored numerous scientific publications.

Michael Kukulinski B.S., L.A.T.G., transitioned into PreLabs in 2008 as Vice President of Operations. Previously, Mike co-founded and served as Vice President of Operations for Biologic Safety Research (BSR) since 1989. In this capacity, he will continue to be instrumental in strategically managing the overall business with a dedicated focus on delivering operational excellence for the newly expanded business.

He has over 30 years of experience in managing vivarium operations as well as serving as study director on thousands of studies ranging from Discovery to Safety Assessment. Mike has established and managed GLP toxicology research operations in AAALAC International-accredited vivaria over the last twenty years. His facility management expertise provides comprehensive facility oversight including regulatory compliance, animal husbandry, technician and toxicological training programs, operational integrity, client confidentiality, on site 24/7 monitored environmental and security systems, along with a focus on expediting protocols through the IACUC process.

Mike has spent most of his career in the CRO environment and has an in-depth understanding and appreciation for regulatory compliance with the Food and Drug Administration (FDA), Consumer Products Safety Commissions Regulations (CPSC), Environmental Protection Agency (EPA/FIFRA & TSCA), Department of Transportation (DOT), Organization for Economic Cooperation and Development (OECD), and other various agencies. He has consulted and conducted toxicity studies on consumer products, industrial chemicals, and components and drug evaluations.

Mr. Kukulinski holds a B.S. degree in Biology with a minor in Chemistry from Ashland University in Ashland, Ohio. He is a certified Laboratory Animal Technologist who also earned an Ophthalmic Toxicology certificate from The Institute for Applied Pharmaceutical Sciences. Michael has co-authored numerous scientific publications.

Robert Locke MS, LATG, transitioned into PreLabs in 2008 as Vice President of Corporate Development after previously serving as Co-Founder and President for Biologic Safety Research Inc (BSR) since 1989. In this capacity, he will continue to be instrumental in managing the expanded organization's overall growth strategy while having direct responsibility for developing and managing the sales, marketing and technical support teams.

Over the last 30 years, Robert co-founded two contract research organizations (Tox Monitor & BSR) and was responsible for creating and leading the respective companies. In his previous roles of responsibility his vision has always been focused on building a long standing tradition of utilizing a highly personalized approach to client interaction. His commitment to scientific and operational integrity has led the way to making sound business decisions while managing thousands of successful acute and preclinical studies.

His extensive outsourcing expertise provides the client with an opportunity to work with an experienced individual who understands the client's scientific requirements while having an appreciation for budgetary constraints and timely study execution. Robert has an impressive reputation for effectively communicating with the sponsor from protocol development through IACUC approval to study execution, concluding with a written report. Robert has an established reputation for being a trusted outsourcing partner.

Mr. Locke holds a B.S. degree from St. Procopius College and a M.S. degree in Anatomy/Reproductive Physiology from Loyola University. He is a certified Laboratory Animal Technologist and has recently celebrated 38 years service as an adjunct Professor of Anatomy at Triton College in suburban Chicago.

Robert Locke MS, LATG, transitioned into PreLabs in 2008 as Vice President of Corporate Development after previously serving as Co-Founder and President for Biologic Safety Research Inc (BSR) since 1989. In this capacity, he will continue to be instrumental in managing the expanded organization's overall growth strategy while having direct responsibility for developing and managing the sales, marketing and technical support teams.

Over the last 30 years, Robert co-founded two contract research organizations (Tox Monitor & BSR) and was responsible for creating and leading the respective companies. In his previous roles of responsibility his vision has always been focused on building a long standing tradition of utilizing a highly personalized approach to client interaction. His commitment to scientific and operational integrity has led the way to making sound business decisions while managing thousands of successful acute and preclinical studies.

His extensive outsourcing expertise provides the client with an opportunity to work with an experienced individual who understands the client's scientific requirements while having an appreciation for budgetary constraints and timely study execution. Robert has an impressive reputation for effectively communicating with the sponsor from protocol development through IACUC approval to study execution, concluding with a written report. Robert has an established reputation for being a trusted outsourcing partner.

Mr. Locke holds a B.S. degree from St. Procopius College and a M.S. degree in Anatomy/Reproductive Physiology from Loyola University. He is a certified Laboratory Animal Technologist and has recently celebrated 38 years service as an adjunct Professor of Anatomy at Triton College in suburban Chicago.

Richard Freund MBA, CPA, CMA, joined PreLabs in 2008 as Controller. He is responsible for the company's financial reporting, tax planning and compliance, and budgeting and business planning. Additionally, he oversees human resources, employee benefits and investor relations.

He has over 20 years of comprehensive financial experience in corporate taxation, financial and management accounting, treasury, employee benefits, banking and risk management. Richard started his career by working as a staff accountant and cost analyst with Automatic Data Processing and Blue Cross Blue Shield respectively. After working in corporate America for four years, he pursued his entrepreneurial ambitions and founded an accounting firm serving primarily high net worth individuals as well as privately held businesses. After a decade of managing the business, he sold the firm and went on to work as a consultant for a national consulting firm that specializes in turning around financially troubled businesses.

A manufacturing concern hired him as their full-time controller after working for six months in a consultative role. He successfully restructured their line of credit and bond issuance with Bank of America. After helping to stabilize the business, he was hired as the Chief Financial Officer for a national consumer lending organization. He was directly responsible for raising over $5M in subordinated debt while helping the company double the number of branch offices during his six years with the firm.

Mr. Freund holds a B.S. degree in accountancy from Northern Illinois University in De Kalb, Illinois and an MBA with an emphasis in finance from De Paul University in Chicago, Illinois. He passed his CPA and CMA examinations in 1985 and 1988 respectively and is a licensed CPA in the state of Illinois.

Richard Freund MBA, CPA, CMA, joined PreLabs in 2008 as Controller. He is responsible for the company's financial reporting, tax planning and compliance, and budgeting and business planning. Additionally, he oversees human resources, employee benefits and investor relations.

He has over 20 years of comprehensive financial experience in corporate taxation, financial and management accounting, treasury, employee benefits, banking and risk management. Richard started his career by working as a staff accountant and cost analyst with Automatic Data Processing and Blue Cross Blue Shield respectively. After working in corporate America for four years, he pursued his entrepreneurial ambitions and founded an accounting firm serving primarily high net worth individuals as well as privately held businesses. After a decade of managing the business, he sold the firm and went on to work as a consultant for a national consulting firm that specializes in turning around financially troubled businesses.

A manufacturing concern hired him as their full-time controller after working for six months in a consultative role. He successfully restructured their line of credit and bond issuance with Bank of America. After helping to stabilize the business, he was hired as the Chief Financial Officer for a national consumer lending organization. He was directly responsible for raising over $5M in subordinated debt while helping the company double the number of branch offices during his six years with the firm.

Mr. Freund holds a B.S. degree in accountancy from Northern Illinois University in De Kalb, Illinois and an MBA with an emphasis in finance from De Paul University in Chicago, Illinois. He passed his CPA and CMA examinations in 1985 and 1988 respectively and is a licensed CPA in the state of Illinois.

Mohammad Khan joined PreLabs in 2008 as Director of I.T.. In this role, he is responsible for overseeing the organization's IT infrastructure and technology-driven initiatives. His responsibilities include the planning and implementation of solutions that will meet the organization's network, data security, communications and web-based applications requirements.

Mohammad has over 10 years of experience in the IT industry and has served in various roles ranging from Data Center Operations, Help Desk, Desktop Support, to Management positions. He also served as the Sr. Lead managing the Enterprise IT Help Desk supporting an end-user environment of 8000+ employees. He has proven success in leading a "World Class" IT team by maintaining a high level of customer satisfaction and initial contact resolution response with internal and external clients.

Furthermore, Mohammad has led several mission-critical implementations including Document Management solutions, Enterprise Portals/Intranets, Voice over IP (VOIP), Storage Area Networks (SAN) as well as coordinating rollouts of thousands of desktop PCs, laptops and servers. He has served as the primary contact for disaster recovery/business continuity for IT and participated in the implementation of enterprise-wide real-time data replication, data integrity and data encryption/security solutions. He has experience in writing business rules, process workflows, SOPs & SLAs and in ensuring they are documented, communicated and carried out.

Mohammad holds a B.S. in Computer Science from University of California, Riverside and several technical certifications including A+, MCP, MCSE, SAP Tech. Con.

Mohammad Khan joined PreLabs in 2008 as Director of I.T.. In this role, he is responsible for overseeing the organization's IT infrastructure and technology-driven initiatives. His responsibilities include the planning and implementation of solutions that will meet the organization's network, data security, communications and web-based applications requirements.

Mohammad has over 10 years of experience in the IT industry and has served in various roles ranging from Data Center Operations, Help Desk, Desktop Support, to Management positions. He also served as the Sr. Lead managing the Enterprise IT Help Desk supporting an end-user environment of 8000+ employees. He has proven success in leading a "World Class" IT team by maintaining a high level of customer satisfaction and initial contact resolution response with internal and external clients.

Furthermore, Mohammad has led several mission-critical implementations including Document Management solutions, Enterprise Portals/Intranets, Voice over IP (VOIP), Storage Area Networks (SAN) as well as coordinating rollouts of thousands of desktop PCs, laptops and servers. He has served as the primary contact for disaster recovery/business continuity for IT and participated in the implementation of enterprise-wide real-time data replication, data integrity and data encryption/security solutions. He has experience in writing business rules, process workflows, SOPs & SLAs and in ensuring they are documented, communicated and carried out.

Mohammad holds a B.S. in Computer Science from University of California, Riverside and several technical certifications including A+, MCP, MCSE, SAP Tech. Con.

Stuart Knight joined Prelabs in 2009 as Global Director of Business Development. He is responsible for developing strategic client relationships with a focus on promoting preclinical testing and other key service offerings to industrial concerns within the international Biotechnology, Medical Device and Pharmaceutical communities. He also plays a significant role in enhancing the visibility of the PreLabs brand awareness through aggressive industry trade affiliations.

Stuart has 20 years of successful international sales and marketing experience. In his most recent role as a senior sales executive with Southern Research Institute he directed sales expansion through a broad spectrum of IND enabling preclinical drug and medical device development and outsourcing services.

He has worked for numerous organizations including Microbiotest, Inc. where he led the sales and marketing effort in executing strategic business development initiatives focused on accelerated growth and increased market share. During his tenure with the Yamazaki Group he developed a successful international licensing and product distribution program.

Stuart received a BS in International Trade and French from Auburn University.

Stuart Knight joined Prelabs in 2009 as Global Director of Business Development. He is responsible for developing strategic client relationships with a focus on promoting preclinical testing and other key service offerings to industrial concerns within the international Biotechnology, Medical Device and Pharmaceutical communities. He also plays a significant role in enhancing the visibility of the PreLabs brand awareness through aggressive industry trade affiliations.

Stuart has 20 years of successful international sales and marketing experience. In his most recent role as a senior sales executive with Southern Research Institute he directed sales expansion through a broad spectrum of IND enabling preclinical drug and medical device development and outsourcing services.

He has worked for numerous organizations including Microbiotest, Inc. where he led the sales and marketing effort in executing strategic business development initiatives focused on accelerated growth and increased market share. During his tenure with the Yamazaki Group he developed a successful international licensing and product distribution program.

Stuart received a BS in International Trade and French from Auburn University.

Richard Shubart, MBA, joined PreLabs in 2009 as Director of Quality Assurance (QA). In his capacity, Richard directs the integration of QA policies and harmonization of facility processes. Additionally his responsibilities include client audit interaction and facilitating regulatory agency inspections.

During his 15 years at Searle, Monsanto and Pharmacia (now Pfizer) he held various positions including Senior Director of Global R&D Quality Assurance where he led a staff of 65 QA professionals. As Director of Quality Assurance at Du Pont Critical Care, he led all QA/QC functions and at Travenol Laboratories (now Baxter), he held management positions in Compliance Programs, GMP audits and GLP.

Among his accomplishments, Richard was responsible for Global R&D QA support in the development of Pfizer's Celebrex, resulting in a successful FDA preapproval inspection and product launch. He also managed the move of Pfizer's European Clinical Pharmacy operations from Belgium to Germany, hired and managed new staff and subsequently validated the new facility. He also managed and successfully relocated the Pfizer's R&D archives from Belgium to a U.S. based site. At Searle, he developed the organization's first R&D computer validation QA group and an engineered approach to software validation in cooperation with the IT group.

Richard received an MBA from Northwestern University, a MS in Chemistry from Roosevelt University and a BS in Chemistry from University of Michigan. He is a member of American Chemical Society (ACS) and American Society of Quality (ASQ). He has been an ASQ certified Quality Engineer since 1982.

Richard Shubart, MBA, joined PreLabs in 2009 as Director of Quality Assurance (QA). In his capacity, Richard directs the integration of QA policies and harmonization of facility processes. Additionally his responsibilities include client audit interaction and facilitating regulatory agency inspections.

During his 15 years at Searle, Monsanto and Pharmacia (now Pfizer) he held various positions including Senior Director of Global R&D Quality Assurance where he led a staff of 65 QA professionals. As Director of Quality Assurance at Du Pont Critical Care, he led all QA/QC functions and at Travenol Laboratories (now Baxter), he held management positions in Compliance Programs, GMP audits and GLP.

Among his accomplishments, Richard was responsible for Global R&D QA support in the development of Pfizer's Celebrex, resulting in a successful FDA preapproval inspection and product launch. He also managed the move of Pfizer's European Clinical Pharmacy operations from Belgium to Germany, hired and managed new staff and subsequently validated the new facility. He also managed and successfully relocated the Pfizer's R&D archives from Belgium to a U.S. based site. At Searle, he developed the organization's first R&D computer validation QA group and an engineered approach to software validation in cooperation with the IT group.

Richard received an MBA from Northwestern University, a MS in Chemistry from Roosevelt University and a BS in Chemistry from University of Michigan. He is a member of American Chemical Society (ACS) and American Society of Quality (ASQ). He has been an ASQ certified Quality Engineer since 1982.